secwatch.observer — SEC 8-K summary
======================================

Issuer:     ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK:        0001281895
Form:       8-K
Filed at:   2024-06-20T23:59:59+00:00
Accession:  0001140361-24-030718
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rocket Pharma increases authorized shares to 180M after shareholder approval
----------------------------------------------------------------------------

- Authorized common shares increased from 120M to 180M (50% increase); amendment effective June 20, 2024.
- All ten director nominees elected; highest vote totals over 71M 'for' votes.
- Ratification of EisnerAmper as independent auditor for FY 2024 approved by ~99.9% of votes cast.
- Non-binding advisory vote on named executive officer compensation passed with ~98.4% of votes cast.
- Voter turnout approximately 87.95% of outstanding shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1281895/000114036124030718/0001140361-24-030718-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1281895/000114036124030718/ef20031374_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-030718

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer